Home › Soft Tissue Sarcoma › District of Columbia
Soft Tissue Sarcoma clinical trials in District of Columbia
6 studies for Soft Tissue Sarcoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's National Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 2 to 30 · All sexes · Updated Nov 5, 2026 · NCT05734066Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
Recruiting
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702Pre-operative Hypofractionated Proton Therapy
- Sibley Memorial Hospital, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT05917301Pediatric Radiation Therapy Registry
- Sibley Memorial Hospital, Washington D.C.
RecruitingObservational study
Ages 0 to 26 · All sexes · Updated Nov 5, 2025 · NCT07129317A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.